|By PR Newswire||
|February 21, 2014 12:54 PM EST||
DUBLIN, Feb. 21, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/v92vqz/nanomedicine) has announced the addition of the "Concise Analysis of the International Nanomedicine Market - Forecast to 2019" report to their offering.
The emergence of nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.Some of thedrivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.
The global nanomedicine market is categorized into six segments on the basis of application, namely neurology, cardiovascular, anti-inflammatory, anti-infective, oncology and others.
Oncology held majority of the market share in 2012 on account of following factors:
- Presence of high number of commercialized nanomedicine products in the market
- Improved bioavailability and efficacy of the tumor specific nanomedicine enabling targeted drug delivery
- Rise in nanomedicine drug formulations replacing conventional drug formulations in cancer treatment
However, the global market for cardiovascular segment is expected to grow at the fastest pace owing to increasing prevalence of cardiovascular diseases demanding drugs with improved efficacy and therapeutic properties. Furthermore, realizing the importance and benefits of nanomedicine, researchers and manufacturers are striving to develop products with improved therapeutic properties in the cardiovascular segment.
The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia-Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region.In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.
Key Topics Covered:
2 Executive Summary
3 Global Nanomedicine Market Overview
4 Global Nanomedicine Market, by Applications
5 Global Nanomedicine Market, by Geography
7 Company Profiles
- Abbott Laboratories
- Celgene Corporation
- CombiMatrix Corporation
- GE Healthcare
- Johnson & Johnson
- Mallinckrodt plc.
- Merck & Company Inc.
- Nanosphere, Inc.
- Pfizer Inc.
- Sigma-Tau Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
For more information visit http://www.researchandmarkets.com/research/v92vqz/nanomedicine
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
Jul. 29, 2016 05:00 AM EDT Reads: 1,418
Jul. 29, 2016 04:45 AM EDT Reads: 2,560
Jul. 29, 2016 04:45 AM EDT Reads: 2,357
Jul. 29, 2016 04:30 AM EDT Reads: 1,395
Jul. 29, 2016 04:15 AM EDT Reads: 2,670
Jul. 29, 2016 03:45 AM EDT Reads: 1,036
Jul. 29, 2016 02:45 AM EDT Reads: 1,598
Jul. 29, 2016 02:30 AM EDT Reads: 1,456
Jul. 29, 2016 02:00 AM EDT Reads: 1,678
Jul. 29, 2016 12:30 AM EDT Reads: 1,700
Jul. 29, 2016 12:15 AM EDT Reads: 1,993
Jul. 29, 2016 12:15 AM EDT Reads: 2,091
Jul. 28, 2016 11:45 PM EDT Reads: 1,243
Jul. 28, 2016 10:15 PM EDT Reads: 2,228
"We've discovered that after shows 80% if leads that people get, 80% of the conversations end up on the show floor, meaning people forget about it, people forget who they talk to, people forget that there are actual business opportunities to be had here so we try to help out and keep the conversations going," explained Jeff Mesnik, Founder and President of ContentMX, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Jul. 28, 2016 10:15 PM EDT Reads: 1,444